These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 17940430)
1. Antiplatelet therapy in type 2 diabetes mellitus. Angiolillo DJ Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430 [TBL] [Abstract][Full Text] [Related]
2. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM; Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948 [TBL] [Abstract][Full Text] [Related]
3. Stroke and atherothrombosis: an update on the role of antiplatelet therapy. Alexandrov AV; Alagona P Int J Stroke; 2008 Aug; 3(3):175-81. PubMed ID: 18705896 [TBL] [Abstract][Full Text] [Related]
4. Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment. Angiolillo DJ; Costa MA; Shoemaker SB; Desai B; Bernardo E; Suzuki Y; Charlton RK; Zenni MM; Guzman LA; Bass TA Am J Cardiol; 2008 Feb; 101(4):440-5. PubMed ID: 18312754 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
6. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Natarajan A; Zaman AG; Marshall SM Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103 [TBL] [Abstract][Full Text] [Related]
7. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel. van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417 [No Abstract] [Full Text] [Related]
8. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Jennings LK Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875 [TBL] [Abstract][Full Text] [Related]
9. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin. Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of platelet aggregation]. Wascher TC Acta Med Austriaca; 2004; 31(5):170. PubMed ID: 15747991 [TBL] [Abstract][Full Text] [Related]
11. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both? Mohler ER Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065 [TBL] [Abstract][Full Text] [Related]
13. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. van Werkum JW; Harmsze AM; Elsenberg EH; Bouman HJ; ten Berg JM; Hackeng CM Platelets; 2008 Nov; 19(7):479-88. PubMed ID: 18979359 [TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z; Kala P Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study. Schimke K; Chubb SA; Davis WA; Phillips P; Davis TM Diabet Med; 2009 Jan; 26(1):70-5. PubMed ID: 19125763 [TBL] [Abstract][Full Text] [Related]
16. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Serebruany V; Pokov I; Kuliczkowski W; Chesebro J; Badimon J Thromb Haemost; 2008 Jul; 100(1):76-82. PubMed ID: 18612541 [TBL] [Abstract][Full Text] [Related]
17. Variability in the response to antiplatelet treatment in diabetes mellitus. Davì G; Vazzana N; Sestili S Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):48-55. PubMed ID: 22330860 [TBL] [Abstract][Full Text] [Related]
18. Influence of antiplatelet medications on bleeding events in hemodialysis patients. Daimon S; Terai H Ther Apher Dial; 2011 Oct; 15(5):454-9. PubMed ID: 21974698 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients. Gurbel PA; DiChiara J; Tantry US Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828 [TBL] [Abstract][Full Text] [Related]